NICE
The National Institute for Health and Care Excellence (NICE) provides national guidance and advice to improve health and social care.
NICE guidelineNICE CKS Otitis externa
This summary has been developed for use by community pharmacists under our Guidelines for Pharmacy title and therefore only covers the information relevant to this setting. Please refer to the full guideline for the complete set of recommendations.
- NICE guideline
Community pharmacies: promoting health and wellbeing
This quality standard covers how community pharmacies can support the health and wellbeing of the local population, and describes high-quality care in priority areas for improvement
- NICE guideline
NICE anaphylaxis guideline
A summary of NICE guidance on assessment to confirm an anaphylactic episode, and a decision-making care pathway for referral after emergency treatment
- NICE guideline
COVID-19 rapid guideline: dialysis service delivery
This Guidelines summary covers the provision of care for patients requiring dialysis in the context of the COVID-19 outbreak
- NICE guideline
NICE CKS analgesia—mild-to-moderate pain
An overview of the analgesics available to treat mild-to-moderate pain in different patient cohorts.
- NICE guideline
COVID-19 rapid guideline: gastrointestinal and liver conditions treated with drugs affecting the immune response
The purpose of this guideline is to maximise the safety of children and adults who have gastrointestinal or liver conditions treated with drugs affecting the immune response during the COVID-19 pandemic.
- NICE guideline
NICE antenatal and postnatal mental health guideline
A concise NICE guideline summary on the management of women with mental health problems during pregancy planning, pregnancy, and the postnatal period.
- NICE guideline
NICE MS guideline
A brief NICE guidance summary relevant to primary care about diagnosis of MS, support for patients, and modifiable risk factors for relapse and progression.
- NICE guideline
NICE antenatal care guideline
A brief summary of NICE guidance on routine care for the healthy pregnant woman. Includes information, lifestyle advice, and foetal and maternal screening.
- NICE guideline
NICE breast cancer guideline
An easy-to-read NICE guidance summary on the classification and care of people at risk of familial breast cancer or with a family history of breast cancer.
- NICE guideline
NICE stable angina guideline
A brief summary of NICE's clinical guideline on the management of stable angina. Includes care pathway algorithm, counselling, and secondary prevention.
- NICE guideline
NICE primary joint replacement guideline
This summary covers the responsibilities of primary care providers for patients before they undergo a planned knee, hip or shoulder replacement
- NICE guideline
NICE epilepsy guideline
A brief, helpful summary of the diagnosis and management of epilepsy in adults and children. Includes status epilepticus management, review, and referral.
- NICE guideline
COVID-19 rapid guideline: delivery of systemic anticancer treatments
This guideline aims to maximise the safety of patients with cancer and make the best use of NHS resources, while protecting staff from infection. It will also enable services to match the capacity for cancer treatment to patient needs if services become limited because of the COVID-19 pandemic
- NICE guideline
NICE CKS—constipation in adults
This summary has been developed for use by community pharmacists under our Guidelines for Pharmacy title, it therefore only covers the information relevant to this setting, and is deliberately concise. Areas covered in the summary include: advice for those with the condition, management (short-duration and chronic), secondary causes of the condition, and prescribing information. Please refer to the full NICE guideline for the complete set of recommendations and references.
- NICE guideline
COVID-19 rapid guideline: children and young people who are immunocompromised
The purpose of this guideline is to maximise the safety of children and young people who are immunocompromised during the COVID-19 pandemic. It also aims to protect staff from infection and enable services to make the best use of NHS resources.
- NICE guideline
COVID-19 rapid guideline: rheumatological autoimmune, inflammatory and metabolic bone disorders
The purpose of this guideline is to maximise the safety of children and adults with rheumatological autoimmune, inflammatory and metabolic bone disorders during the COVID-19 pandemic, while protecting staff from infection. It also enables services to make the best use of NHS resources
- NICE guideline
Venous thromboembolic diseases: diagnosis, management and thrombophilia testing
This useful summary covers diagnosis and initial management, outpatient treatment for low-risk pulmonary embolism, anticoagulation treatment for suspected or confirmed deep vein thrombosis or pulmonary embolism, and information and support for people having anticoagulation treatment
- NICE guideline
COVID-19 rapid guideline: chronic kidney disease
This COVID-19 rapid guideline aims to maximise the safety of adults with chronic kidney disease during the COVID-19 pandemic. It also aims to protect staff from infection and enable services to make the best use of NHS resources.
- NICE guideline
COVID-19 rapid guideline: dermatological conditions treated with drugs affecting the immune response
The purpose of this Guidelines summary is to maximise the safety of children and adults who have dermatological conditions treated with drugs affecting the immune response during the COVID-19 pandemic.
